Tevogen Bio Holdings Inc. — Cash Flow Charts
10 quarters of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-52.9% -$1M
$-3M
Free Cash Flow↓-52.9% -$1M
$-3M
Investing Cash Flow
$0
Financing Cash Flow↓-20.0% -$999K
$4M
Capex
$0
Stock Buybacks
$10M
Stock-Based Comp↓-2.5% -$83K
$3M
D&A↓-98.7% -$40K
$518
SBC Allocated Expense↓-2.5% -$83K
$3M